Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) EV/EBITDA
As of 25 September 2026, Henry Schein, Inc. (HSIC) trades at a EV/EBITDA of 12.0×. Over the past ten years it has ranged from 7.7× (April 2020) to 19.7× (December 2018); the current reading is higher than 49% of that period. That is below the Medical Distribution industry median of 15.5× and above the Healthcare sector median of 10.4×.
EV/EBITDA, daily
Annual
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 11.7× | 3.62% |
| FY2024 | 11.3× | (14.43%) |
| FY2023 | 13.2× | 7.99% |
| FY2022 | 12.3× | 12.60% |
| FY2021 | 10.9× | (19.32%) |
| FY2020 | 13.5× | 16.23% |
| FY2019 | 11.6× | (16.35%) |
| FY2018 | 13.9× | 16.97% |
| FY2017 | 11.9× | 5.37% |
| FY2016 | 11.3× | (5.88%) |
Quarterly
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 11.7× | 6.86% |
| Mar 2026 | 10.9× | (6.86%) |
| Dec 2025 | 11.7× | 12.67% |
| Sep 2025 | 10.4× | (9.00%) |
| 42 more quarters | Free account |
Against its own ten years
Low 7.7×
High 19.7×
Ten-year median
12.0×
Current reading's percentile
49
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| COSM Cosmos Health Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| ACH Accendra Health, Inc. compare | 8.2× |
| HSIC Henry Schein, Inc. | 12.0× |
| MCK McKesson Corporation compare | 15.5× |
| CAH Cardinal Health, Inc. compare | 15.7× |
| COR Cencora, Inc. compare | 16.6× |
| Medical Distribution industry median | 15.5× |
| Healthcare sector median | 10.4× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement